Please enable Javascript to use all features and improve your user experience.
EHC 2024
Programme
Posters
Search
EN
Back
Poster session
PoS 1
ePoster 01
Appointment
Date:
04.12.
Time:
17:00
–
18:00
Location / Stream:
ePoster station 1
Programme
ePoster
P001
Constipation as an adverse effect of all the subcutaneous anti CGRP monoclonal antibodies: relation to pre-existing constipation and impact on migraine treatment
Teresa Ascensão Pinheiro (Amadora, PT)
ePoster
P002
Calcitonin gene-related peptide monoclonal antibodies and concomitant autoimmune related disorders
Bruno Carvalho (Porto, PT)
ePoster
P003
Blood pressure in migraine patients undergoing treatment with CGRP monoclonal antibodies in patients with migraine – a systematic review and potential implications for clinical practice
Britt W.H. van der Arend (Leiden, NL)
ePoster
P004
Anti-CGRP monoclonal antibodies treatment discontinuation in migraine: when and why
Teresa Mateu (Barcelona, ES)
ePoster
P005
Efficacy and safety of rimegepant for the preventive treatment of fasting-related headache during Ramadan in the UAE
Taoufik Alsaadi (Abu Dhabi, AE)
ePoster
P006
Efficacy and safety of rimegepant for the acute treatment of migraine in Japan
Terence Fullerton (Groton, CT, US)
ePoster
P007
Efficacy and safety of rimegepant for the prevention of migraine in Japan
Terence Fullerton (Groton, CT, US)
ePoster
P008
Consistency of effect of rimegepant as an acute treatment for migraine attacks: Data from a real-world survey
Lucy Abraham (Tadworth, GB)
ePoster
P009
Cognitive improvement in a patient undergoing Eptinezumab for the treatment of chronic migraine – a case report
Mona Hirt (Zürich, CH)
ePoster
P010
Real-world effectivenes and tolerability of switching between CGRP pathway tageting antibodies: Czech Migraine Registry (ReMig)
Tomáš Nežádal (Prag, CZ)
ePoster
P011
Fremanezumab for the treatment of migraine and medication overuse headache – a systematic review and meta-analysis
Lanfranco Pellesi (Odense, DK)
ePoster
P012
Effectiveness and safety of anti-CGRP treatment in migraine patients with autoimmune diseases: multicenter "ImmunoCGRP" case-control study
Alicia González Martínez (Madrid, ES)
v1.20.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy